EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of hepatocellular carcinoma growth via modulation of the miR-221/SOX11 axis by curcumin and berberine

Sheng Li, Xiaoliang Cai, Liang Chen, Manbian Lin, Ziqi Zhu, Huihuang Xiao, Pingping Nie, Quanwen Chen, Xiaoyu Yang

PeerJ · 2023

DOI: 10.7717/peerj.16593 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2023. Verfasst von Sheng Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Fuzhou Hospital of Traditional Chinese Medicine, Fuzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Curcumin, Liver Neoplasms, Berberine. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bureau of Science and Technology of Fuzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is a fatal malignancy that has limited treatment options. This study focused on the potential therapeutic effects of curcumin (CUR) and berberine (BBR) on the miR-221/SRY-box transcription factor 11 (SOX11) axis in HCC. We investigated the combined effects of CUR and BBR on HEPG2 and Huh7 cell survival and miR-221 expression using Cell Counting Kit-8 assays and RT-qPCR, respectively. Western blotting was used to detect changes in the apoptosis-related caspase-3/9 protein levels. We performed bioinformatics analysis and dual-luciferase assays and measured apoptotic protein levels to assess the role of the miR-221/SOX11 axis in mediating the effects of CUR-BBR. Both CUR and BBR suppressed HCC cell growth in a dose-dependent manner, with the most potent combined effect observed at a 2:1 ratio. CUR-BBR treatment significantly downregulated miR-221 expression, and miR-221 overexpression partially reversed the CUR-BBR-mediated decrease in cell survival. In addition, SOX11 was found to be a direct target of miR-221. CUR-BBR treatment upregulated SOX11 expression, and overexpression of SOX11 restored the inhibitory effects of CUR-BBR on cell growth, migration, and invasion and promoted apoptosis in the presence of miR-221. Furthermore, CUR-BBR activated pro-apoptotic proteins caspase-3/9 through the miR-221/SOX11 axis. The combined effect of CUR-BBR played an important role in inhibiting the growth of HCC cells. This combined effect was achieved by regulating the miR-221/SOX11 axis and activating the synthesis of pro-apoptotic proteins. Our findings highlight a promising combined therapeutic approach for HCC and underscore the importance of targeting the miR-221/SOX11 axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularCurcuminLiver NeoplasmsBerberineMicroRNAsHumansCaspase 3SOXC Transcription Factors

Stichwörter der Autor:innen

BerberineCurcuminHCCSOX11miR-221

Substanzen

CurcuminBerberineCaspase 3MicroRNAsSOXC Transcription FactorsSOX11 protein, humanMIR221, human

Autor:innen und Institutionen

  • Department of Internal Medicine, Fuzhou Hospital of Traditional Chinese Medicine, Fuzhou, China.
  • Department of Medical Oncology, Fuzhou Hospital of Traditional Chinese Medicine, Fuzhou, China.
  • Fuzhou Hospital of Traditional Chinese Medicine, Fuzhou, China.

Förderung

  • Bureau of Science and Technology of Fuzhou

Zitieren

APA

Li, S., Cai, X., Chen, L., Lin, M., Zhu, Z., Xiao, H., Nie, P., Chen, Q., & Yang, X. (2023). Inhibition of hepatocellular carcinoma growth via modulation of the miR-221/SOX11 axis by curcumin and berberine. PeerJ. https://doi.org/10.7717/peerj.16593

Vancouver

Li S, Cai X, Chen L, Lin M, Zhu Z, Xiao H, et al. Inhibition of hepatocellular carcinoma growth via modulation of the miR-221/SOX11 axis by curcumin and berberine. PeerJ. 2023. doi:10.7717/peerj.16593

BibTeX
@article{Li2023,
  author = {Li, Sheng and Cai, Xiaoliang and Chen, Liang and Lin, Manbian and Zhu, Ziqi and Xiao, Huihuang and Nie, Pingping and Chen, Quanwen and Yang, Xiaoyu},
  title = {Inhibition of hepatocellular carcinoma growth via modulation of the miR-221/SOX11 axis by curcumin and berberine},
  journal = {PeerJ},
  year = {2023},
  doi = {10.7717/peerj.16593}
}
Kostenlos starten →